Movement Alert｜XtalPi Holdings Rises 5.1% in Regular Trading, Multiple Catalysts Including AI Workstation Deployment and Sector Strength

Market Focus

07/02

On July 2, XtalPi Holdings rose 5.1% in regular trading, trading at HKD 7.8/share, with turnover of HKD 291 million.

On the news front, the company has recently seen a cluster of positive developments. Its AI autonomous experiment workstation was officially deployed at Sinopec, marking substantial progress in extending its AI+robotics platform into materials science. Earlier, the company announced a strategic AI drug discovery partnership with a leading international pharmaceutical company valued at over USD 400 million, focusing on oral small-molecule therapies targeting GPCR. Additionally, a USD 100 million share buyback program has been underway since June 10, signaling management confidence in the company's intrinsic value.

The broader life sciences sector rallied on the same day, with GenScript Biotech up 3.84%, WuXi Biologics up 3.06%, and WuXi XDC up 2.8%, providing additional momentum through sector-wide strength.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1180844954"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1180844954\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1180844954?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 10:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180844954","market":"us","top_or_hot":-1,"title":"Movement Alert｜XtalPi Holdings Rises 5.1% in Regular Trading, Multiple Catalysts Including AI Workstation Deployment and Sector Strength","media":"Market Focus","content":"<p><p>On July 2, XtalPi Holdings rose 5.1% in regular trading, trading at HKD 7.8/share, with turnover of HKD 291 million.</p><p>On the news front, the company has recently seen a cluster of positive developments. Its AI autonomous experiment workstation was officially deployed at Sinopec, marking substantial progress in extending its AI+robotics platform into materials science. Earlier, the company announced a strategic AI drug discovery partnership with a leading international pharmaceutical company valued at over USD 400 million, focusing on oral small-molecule therapies targeting GPCR. Additionally, a USD 100 million share buyback program has been underway since June 10, signaling management confidence in the company's intrinsic value.</p><p>The broader life sciences sector rallied on the same day, with GenScript Biotech up 3.84%, WuXi Biologics up 3.06%, and WuXi XDC up 2.8%, providing additional momentum through sector-wide strength.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜XtalPi Holdings Rises 5.1% in Regular Trading, Multiple Catalysts Including AI Workstation Deployment and Sector Strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜XtalPi Holdings Rises 5.1% in Regular Trading, Multiple Catalysts Including AI Workstation Deployment and Sector Strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-02 10:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 2, XtalPi Holdings rose 5.1% in regular trading, trading at HKD 7.8/share, with turnover of HKD 291 million.</p><p>On the news front, the company has recently seen a cluster of positive developments. Its AI autonomous experiment workstation was officially deployed at Sinopec, marking substantial progress in extending its AI+robotics platform into materials science. Earlier, the company announced a strategic AI drug discovery partnership with a leading international pharmaceutical company valued at over USD 400 million, focusing on oral small-molecule therapies targeting GPCR. Additionally, a USD 100 million share buyback program has been underway since June 10, signaling management confidence in the company's intrinsic value.</p><p>The broader life sciences sector rallied on the same day, with GenScript Biotech up 3.84%, WuXi Biologics up 3.06%, and WuXi XDC up 2.8%, providing additional momentum through sector-wide strength.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02228","symbol_name":"晶泰控股","start_time":0,"source_url":"","article_id":"1180844954","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180844954","pubTimestamp":1782958556,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 2, XtalPi Holdings rose 5.1% in regular trading, trading at HKD 7.8/share, with turnover of HKD 291 million.On the news front, the company has recently seen a cluster of positive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02228":"晶泰控股"},"translate_title":"动向提示|XtalPi Holdings在常规交易中上涨5.1%，包括AI工作站部署和板块走强在内的多重催化剂","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02228":1},"content_text":"On July 2, XtalPi Holdings rose 5.1% in regular trading, trading at HKD 7.8/share, with turnover of HKD 291 million.On the news front, the company has recently seen a cluster of positive developments. Its AI autonomous experiment workstation was officially deployed at Sinopec, marking substantial progress in extending its AI+robotics platform into materials science. Earlier, the company announced a strategic AI drug discovery partnership with a leading international pharmaceutical company valued at over USD 400 million, focusing on oral small-molecule therapies targeting GPCR. Additionally, a USD 100 million share buyback program has been underway since June 10, signaling management confidence in the company's intrinsic value.The broader life sciences sector rallied on the same day, with GenScript Biotech up 3.84%, WuXi Biologics up 3.06%, and WuXi XDC up 2.8%, providing additional momentum through sector-wide strength.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}